|
시장보고서
상품코드
1970770
합성생물학 툴 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Synthetic Biology Tools Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
합성생물학 툴 시장 규모는 2025년 193억 달러에서 2034년에는 843억 6,000만 달러에 이르고, 2026-2034년 CAGR 17.81%를 나타낼 전망입니다.
생물학과 공학의 융합이 헬스케어, 농업, 산업 생명공학 분야의 혁신을 주도하는 가운데, 세계 합성생물학 도구 시장은 빠르게 성장하고 있습니다. CRISPR 유전자 편집 시스템, DNA 합성 플랫폼, 고급 생물정보학 소프트웨어 등 합성생물학 도구는 생물학적 시스템에 대한 전례 없는 제어를 가능하게 하고 있습니다. 이러한 발전은 신약 개발, 작물 개량, 바이오연료 개발, 지속 가능한 화학물질 생산에 적용을 가속화하고 있습니다.
높은 처리량 자동화, 오류 보정 방법, 비용 효율적인 유전자 합성 기술의 지속적인 개선으로 합성 생물학 기술에 대한 접근이 민주화되고 있습니다. 클라우드 기반 플랫폼과 AI 기반 분석과의 통합을 통해 데이터 관리의 효율성을 높이고, 설계-구축-테스트-학습(DBTL) 주기를 단축할 수 있습니다. 학계와 스타트업 기업들은 상업적 잠재력을 가진 새로운 합성 경로와 디자인 생물체 개발을 위해 업계 리더과 협력을 강화하고 있습니다.
앞으로의 기회는 프로그램 가능한 세포치료, 환경 모니터링용 바이오센서, 주문형 바이오 파운드리, 주문형 생체 설계가 가능한 바이오 파운드리에 있습니다. 전 세계 산업계가 지속가능성과 순환형 바이오경제 모델을 우선시하는 가운데, 합성생물학 도구는 석유 유래 공정을 재생 가능한 생물학적 대안으로 대체하는 데 있어 핵심적인 역할을 할 것입니다. 이 시장은 차세대 바이오테크놀러지의 초석이 될 것이며, 여러 분야에 걸쳐 혁신적인 혁신을 불러일으킬 것으로 기대되고 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 합성생물학 툴 시장 : 제품별
제5장 세계의 합성생물학 툴 시장 : 기술별
제6장 세계의 합성생물학 툴 시장 : 용도별
제7장 세계의 합성생물학 툴 시장 : 최종 용도별
제8장 세계의 합성생물학 툴 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
LSH 26.03.23The Synthetic Biology Tools Market size is expected to reach USD 84.36 Billion in 2034 from USD 19.30 Billion (2025) growing at a CAGR of 17.81% during 2026-2034.
The global synthetic biology tools market is expanding rapidly as the convergence of biology and engineering drives innovation across healthcare, agriculture, and industrial biotechnology. Synthetic biology tools such as CRISPR gene-editing systems, DNA synthesis platforms, and advanced bioinformatics software are enabling unprecedented control over biological systems. These advancements are accelerating applications in drug discovery, crop engineering, biofuel development, and sustainable chemical production.
Continuous improvements in high-throughput automation, error-correction methods, and cost-efficient gene synthesis are democratizing access to synthetic biology capabilities. Integration with cloud-based platforms and AI-driven analytics is streamlining data management, facilitating faster design-build-test-learn (DBTL) cycles. Academic institutions and startups are increasingly collaborating with industry leaders to develop novel synthetic pathways and engineered organisms with commercial potential.
Future opportunities lie in programmable cell therapies, biosensors for environmental monitoring, and biofoundries capable of on-demand organism design. As global industries prioritize sustainability and circular bioeconomy models, synthetic biology tools will play a central role in replacing petroleum-based processes with renewable biological alternatives. The market is set to remain a cornerstone of next-generation biotechnology, unlocking transformative innovations across multiple sectors.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Oligonucleotide/Oligo Pools and Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Xeno-Nucleic Acids
- Chassis Organism
By Technology
- NGS Technology
- PCR Technology
- Genome Editing Technology
- Bioprocessing Technology
- Other Technologies
By Application
- Healthcare
- Non-healthcare
By End Use
- Biotechnology and Pharmaceutical companies
- Academic and Research Institutes
- Others
COMPANIES PROFILED
- Bota Biosciences Inc, Codexis Inc, Creative Biogene, Creative Enzymes, Enbiotix Inc, Illumina Inc, Merck KGaA SigmaAldrich Co LLC, New England Biolabs, Eurofins Scientific, Novozymes, Pareto Bio Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Oligonucleotide/Oligo Pools and Synthetic DNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Cloning Technologies Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Xeno-Nucleic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.6. Chassis Organism Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Technology
- 5.2. NGS Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. PCR Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Genome Editing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Bioprocessing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY APPLICATION 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Application
- 6.2. Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Non-healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY END USE 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End Use
- 7.2. Biotechnology and Pharmaceutical companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY REGION 2022-2034(USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Product
- 8.2.2 By Technology
- 8.2.3 By Application
- 8.2.4 By End Use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Product
- 8.3.2 By Technology
- 8.3.3 By Application
- 8.3.4 By End Use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Product
- 8.4.2 By Technology
- 8.4.3 By Application
- 8.4.4 By End Use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Product
- 8.5.2 By Technology
- 8.5.3 By Application
- 8.5.4 By End Use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Product
- 8.6.2 By Technology
- 8.6.3 By Application
- 8.6.4 By End Use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL SYNTHETIC BIOLOGY TOOLS INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Bota Biosciences Inc
- 10.2.2 Codexis Inc
- 10.2.3 Creative Biogene
- 10.2.4 Creative Enzymes
- 10.2.5 Enbiotix Inc
- 10.2.6 Illumina Inc
- 10.2.7 Merck KGaA (Sigma-Aldrich Co. LLC)
- 10.2.8 New England Biolabs
- 10.2.9 Eurofins Scientific
- 10.2.10 Novozymes
- 10.2.11 Pareto Bio Inc
